A new entrant in the specialized field of gene construct engineering, Houdini Bio, has secured $1.9M in pre-seed funding. The round saw participation from SCVC, Deep Science Ventures, and Cambridge Enterprise Ventures.
Houdini Bio's core work involves engineering gene constructs specifically designed to escape existing performance limits, a focus that attracted this early-stage investment.















